Westlake Genetech to Showcase Two Research Achievements at 2024 ASGCT Annual Meeting

Westlake Genetech. Ltd. announced participation in the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), to be held at the Baltimore Convention Center in Baltimore, Maryland, from May 7 to 11, 2024 (Eastern Time, USA). The company will deliver two oral presentations, highlighting its leading AAV gene therapy delivery platform and its AAV targeting CNS and muscle, and in vivo CAR-T therapy.

Meeting Core Information

• Meeting Name: ASGCT 2024 - 27th Annual Meeting of the American Society of Gene & Cell Therapy
• Date: May 7-11, 2024 (Eastern Time, USA)
• Venue: Baltimore Convention Center, Baltimore, MD, USA

Oral Presentation Details

Presentation 1

• Title: An AI-Generated Novel AAV Variant Targeting Pan-Muscle and Sparing from the Liver in NHP
• Session Time: THURSDAY, MAY 09 2024
• Presentation Time: 03:45 PM - 04:00 PM
• Session Room: ROOM 309-310
• Type: Oral Abstract Session
• Abstract Number: 212

Presentation 2

• Title: An Evolved AAV Variant Enables In Vivo CAR-T Cell Generation, Tumor Cytotoxicity, and B Cell Elimination
• Session Time: SATURDAY, MAY 11 2024
• Presentation Time: 11:15 AM - 11:30 AM
• Session Room: BALLROOM 4
• Type: Oral Abstract Session
• Abstract Number: 391

About Westlake Genetech

Westlake Genetech is an innovative biotech company focused on leveraging AI to accelerate the research and development of next-generation gene therapies. Through the proprietary gene therapy technology platforms, the company has achieved significant technological breakthroughs in capsid engineering and payload redesigning, including novel AAV variants with tropism for T cells, CNS and muscle tissues, as well as optimized gene-editing tools. These innovations will help drive the development of safer, more accessible and more efficient gene therapies to address more unmet needs.

About ASGCT

Founded in 1996, the American Society of Gene & Cell Therapy (ASGCT) is the world's largest non-profit medical organization dedicated to gene and cell therapy research. As the most authoritative and credible institution in the global gene and cell therapy sector, it boasts over 2,500 members worldwide. The ASGCT Annual Meeting is the premier academic event in the field, providing an international platform for participants to present the latest advancements in gene and cell therapies and engage in critical discussions.

Contacts: bd@westlakegenetech.com